Sonigo; Pierre

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sonigo; Pierre.The latest application filed is for "cloned dna sequences related to the entire genomic rna of human immunodeficiency virus ii (hiv-2), polypeptides encoded by these dna sequences and use of these dna clones and polypeptides in diagnostic kits".

Company Profile

0.28.10

Sonigo; Pierre - Paris N/A FR
Sonigo; Pierre - Gutenberg FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 Grant 8,507,196 - Alizon , et al. August 13, 2	2013-08-13
Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) Grant 8,329,396 - Alizon , et al. December 11, 2	2012-12-11
Nucleic acids obtained from LAV.sub.MAL, a variant African AIDS virus Grant 7,767,800 - Alizon , et al. August 3, 2	2010-08-03
HIV-1 DNA fragments that hybridize to genomic HIV-1DNA Grant 7,626,013 - Alizon , et al. December 1, 2	2009-12-01
Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity Grant 7,585,619 - Alizon , et al. September 8, 2	2009-09-08
Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA Grant 7,351,412 - Alizon , et al. April 1, 2	2008-04-01
HIV-2 antigen compositions Grant 7,341,731 - Montagnier , et al. March 11, 2	2008-03-11
DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) Grant 7,232,654 - Chermann , et al. June 19, 2	2007-06-19
Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) Grant 7,217,508 - Wain-Hobson , et al. May 15, 2	2007-05-15
DNA sequences and peptides of human immunodeficiency virus (HIV-1) Grant 7,119,181 - Alizon , et al. October 10, 2	2006-10-10
Retrovirus capable of causing AIDS, means and methods for detecting it in vitro Grant 7,115,363 - Montagnier , et al. October 3, 2	2006-10-03
Antibodies against antigens of human immunodeficiency virus (HIV-1) Grant 7,045,130 - Alizon , et al. May 16, 2	2006-05-16
Variant of LAV viruses Grant 7,029,679 - Alizon , et al. April 18, 2	2006-04-18
Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays Grant 6,979,535 - Alizon , et al. December 27, 2	2005-12-27
Variant of LAV viruses Grant 6,951,648 - Alizon , et al. October 4, 2	2005-10-04
Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA Grant 6,894,152 - Alizon , et al. May 17, 2	2005-05-17
Variant of LAV viruses Grant 6,730,304 - Alizon , et al. May 4, 2	2004-05-04
Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene Grant 6,706,268 - Alizon , et al. March 16, 2	2004-03-16
Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits App 20030235835 - Alizon, Marc ; et al.	2003-12-25
Method for preparing a viral extract containing HIV-II RNA Grant 6,664,041 - Montagnier , et al. December 16, 2	2003-12-16
Variant of LAV viruses App 20030224352 - Alizon, Marc ; et al.	2003-12-04
Variant of LAV viruses Grant 6,635,752 - Alizon , et al. October 21, 2	2003-10-21
HIV-2 antigen compositions App 20030170658 - Montagnier, Luc ; et al.	2003-09-11
Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits App 20030091985 - Alizon, Marc ; et al.	2003-05-15
Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays App 20030082523 - Alizon, Marc ; et al.	2003-05-01
Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2 Grant 6,544,728 - Alizon , et al. April 8, 2	2003-04-08
Variant of LAV viruses App 20020177128 - Alizon, Marc ; et al.	2002-11-28
Variant of LAV viruses App 20020086285 - Alizon, Marc ; et al.	2002-07-04
Variant of LAV viruses App 20020076691 - Alizon, Marc ; et al.	2002-06-20
A Method For Preparing A Viral Extract Containing Hiv-ii Rna App 20020051967 - Montagnier, Luc ; et al.	2002-05-02
Variant of LAV viruses App 20020022033 - Alizon, Marc ; et al.	2002-02-21
Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits Grant 6,261,762 - Alizon , et al. July 17, 2	2001-07-17
Human immunodeficiency virus type 2 (HIV-2) polypeptides and methods of producing them Grant 6,162,439 - Alizon , et al. December 19, 2	2000-12-19
In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies Grant 6,048,685 - Alizon , et al. April 11, 2	2000-04-11
Oligonucleotide sequences for the amplification of the genome of the retroviruses of the HIV-2 and SIV type, and their uses for in vitro diagnosis of the infections due to these viruses Grant 6,020,123 - Sonigo , et al. February 1, 2	2000-02-01
Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2) Grant 5,306,614 - Alizon , et al. * April 26, 1	1994-04-26
Peptides related to human immunodeficiency virus II (HIV-2) Grant 5,051,496 - Alizon , et al. September 24, 1	1991-09-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.